Ainos (NASDAQ:AIMD) Shares Climb 1.5% – Here’s What Happened

Ainos, Inc. (NASDAQ:AIMD)’s share price was up 1.5% on Tuesday. The stock traded as high as $0.8565 and last traded at $0.7946. Approximately 4,925 shares changed hands during mid-day trading, The stock had previously closed at $0.7825.

Wall Street Analyst Weigh In

Separately, Weiss Ratings upgraded Ainos from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Friday, September 25th. One analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, Ainos presently has a consensus rating of “Sell”.

Ainos Stock Performance

The company’s 50-day moving average price is $1.27 and its two-hundred day moving average price is $1.61. The stock has a market cap of $5.38 million, a PE ratio of -0.29 and a beta of 2.47.

Ainos (NASDAQ:AIMD) last announced its earnings results on Monday, August 3rd. The company reported ($0.62) earnings per share (EPS) for the quarter.

About Ainos

Ainos, Inc is a healthcare technology company focused on developing artificial intelligence-enabled point-of-care testing, telehealth solutions and low-dose interferon therapeutics. Its technologies are intended to support faster, more accessible testing and treatment in clinical and other healthcare settings.

The company’s development portfolio has included AI Nose, a platform designed to analyze volatile organic compounds for potential disease screening, as well as Ainos Flora, a point-of-care molecular testing product being developed for the detection of common vaginal infections.